TAINAN, Taiwan, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Himax Technologies, Inc. (“Himax” or “Company”) (Nasdaq: HIMX), an industry leader in fabless display driver ICs and other semiconductors, today ...
HANOI, VIETNAM - Newswire - 27 December 2024 - Driven by the vision of widespread electrification, VinFast is dedicated to ...
About JinkoSolar Holding Co., Ltd. JinkoSolar (NYSE: JKS) is one of the largest and most innovative solar module manufacturers in the world. JinkoSolar distributes its solar products and sells its ...
Portfolio Optimization: Streamlining investments to prioritize high-return ventures and discontinuing underperformed and ...
MCLEAN, Va., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) today published on its website the National Association of Insurance Commissioners (NAIC) 2024 filing year designations for ...
The annual J.P. Morgan Healthcare Conference is the largest and most informative event for the global pharmaceutical industry and the investment community. This year, the conference will take place in ...
For 1win, 2024 has become the year of philanthropy, environmental sustainability, and sports development investments. From bringing free healthcare and distributing meals to promoting a sporty ...
美國馬裡蘭州羅克維爾市和中國蘇州2024年12月27日 /美通社/ -- 致力於在腫瘤等領域開發創新藥物的領先的生物醫藥企業——亞盛醫藥（6855.HK）今日宣布，公司董事長、CEO楊大俊博士受邀將於美西時間2025年1月16日下午1:15（北京時間1月17日凌晨05:15）在第43屆摩根大通醫療健康年會上發表演講，展示亞盛醫藥在以患者為中心的全球創新戰略下的成就與未來展望。
The Global OBGYN EHR (Obstetrics and Gynecology Electronic Health Record) Market, valued at approximately USD 1.6 billion in 2022, is projected to grow at a robust CAGR of more than 9.50% during the ...
ROBESONIA, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) -- Blaqclouds, Inc. (OTC: BCDS) - Prepare to redefine your shopping experience ...
TAIPEI, Dec. 26, 2024 /PRNewswire/ -- VIVOTEK (3454-TW), the global leading security solution provider, has once again ...
To maximize its cash runway while the Board conducts its review of strategic alternatives, Viracta has elected to close its ongoing pivotal Phase 2 clinical trial of Nana-val in relapsed/refractory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback